{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:16:29Z","timestamp":1789676189520,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the clinical performance of cell-free DNA (cfDNA) screening as a primary screening tool for autosomal recessive conditions in a large, prospective, general-risk population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a prospective analysis of pregnant individuals who underwent carrier screening with a reflex cfDNA fetal risk assessment at nine participating U.S. institutions. The conditions evaluated included cystic fibrosis, spinal muscular atrophy, and beta and alpha hemoglobinopathies. The cfDNA results were categorized as high risk (at least 1-in-4 predicted fetal risk) or low risk. Test performance metrics were calculated using Wilson Score 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>There were 2,403 cfDNA results among 2,212 pregnant carriers with singleton pregnancies at a gestational age of at least 10 weeks at participating sites (188 individuals were carriers for more than one condition). The neonatal or fetal outcome was known for 2,369 (98.6%) cfDNA results. A cfDNA fetal risk of at least 1 in 4 was returned for 1.3%, and the cfDNA fetal risk test had a specificity of 99.5%, a negative predictive value of 99.9%, a sensitivity of 94.4%, and a positive predictive value (PPV) of 58.6%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In this large, racially and ethnically diverse general-risk pregnant carrier sample, cfDNA fetal risk assessment accurately distinguished high-risk and low-risk pregnancies with greater PPV than traditional carrier screening, without requiring a partner sample. Combined with prior peer-reviewed studies that assessed cfDNA fetal risk screens, these findings support the possibility of cfDNA fetal risk assessment as a primary screen to identify pregnancies at high risk for autosomal recessive conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006403","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:00:21Z","timestamp":1786654821000},"page":"509-515","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Prospective, Multi-Site Study of Performance of Cell-Free DNA Testing for Recessive Conditions in a Large, General-Risk Pregnancy Population"],"prefix":"10.1097","volume":"148","author":[{"given":"Eliza R.","family":"McElwee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Levan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hoskovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalonna","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesslyn","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shondel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylan","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Wiggins-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Cristina","family":"Filetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Helton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Alvarez Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Czerwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunbola S.","family":"Ashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta L.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"14382","DOI":"10.1038\/s41598-019-50378-8","article-title":"A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT","volume":"9","author":"Tsao","year":"2019","journal-title":"Sci Rep"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"100334","DOI":"10.1016\/j.gim.2022.10.014","article-title":"Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions","volume":"25","author":"Hoskovec","year":"2023","journal-title":"Genet Med"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/pd.6427","article-title":"Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting","volume":"43","author":"Wynn","year":"2023","journal-title":"Prenat Diagn"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcf.2025.08.004","article-title":"Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy","volume":"24","author":"Wynn","year":"2025","journal-title":"J Cyst Fibros"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/clinchem\/hvag005","article-title":"Simultaneous prenatal cfDNA screening of aneuploidy, recessive single-gene conditions, and fetomaternal blood compatibility","volume":"72","author":"Wang","year":"2026","journal-title":"Clin Chem"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pd.5588","article-title":"It takes two: uptake of carrier screening among male reproductive partners","volume":"40","author":"Giles Choates","year":"2020","journal-title":"Prenat Diagn"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"100831","DOI":"10.1016\/j.gimo.2023.100831","article-title":"The completion of indicated paternal prenatal genetic and carrier testing at a public hospital in Los Angeles, California","volume":"1","author":"Nguyen","year":"2023","journal-title":"Genet Med Open"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pd.5824","article-title":"Reproductive male partner testing when the female is identified to be a genetic disease carrier","volume":"41","author":"Simone","year":"2021","journal-title":"Prenat Diagn"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jgc4.1333","article-title":"Perceived barriers to paternal expanded carrier screening following a positive maternal result: to screen or not to screen","volume":"30","author":"Carlotti","year":"2021","journal-title":"J Genet Couns"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/ijns10030049","article-title":"Systematic review of newborn screening programmes for spinal muscular atrophy","volume":"10","author":"Cooper","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000472370","article-title":"Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens","volume":"2","author":"Lorey","year":"1994","journal-title":"Eur J Hum Genet"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","article-title":"Verification of forecasts expressed in terms of probability","volume":"78","author":"Brier","year":"1950","journal-title":"Monthly Weather Rev"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/pd.70098","article-title":"Translating emerging data for fetal treatment of cystic fibrosis","volume":"46","author":"Zaretsky","year":"2026","journal-title":"Prenat Diagn"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1182\/bloodadvances.2021005916","article-title":"Consensus statement for the perinatal management of patients with \u03b1 thalassemia major","volume":"5","author":"MacKenzie","year":"2021","journal-title":"Blood Adv"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMc2300802","article-title":"Risdiplam for prenatal therapy of spinal muscular atrophy","volume":"392","author":"Finkel","year":"2025","journal-title":"N Engl J Med"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"201673","DOI":"10.1016\/j.omta.2026.201673","article-title":"Elective preterm birth for earlier spinal muscular atrophy treatment","volume":"34","author":"Dangouloff","year":"2026","journal-title":"Mol Ther Adv"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","article-title":"Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat Med"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","article-title":"Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat Med"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gim.2021.09.009","article-title":"A guidelines-consistent carrier screening panel that supports equity across diverse populations","volume":"24","author":"Johansen Taber","year":"2022","journal-title":"Genet Med"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/AOG.0000000000004224","article-title":"Racial and ethnic disparities in reproductive health services and outcomes, 2020","volume":"137","author":"Sutton","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/pd.6338","article-title":"Equitable delivery of expanded genetic technologies: considerations for prenatal and reproductive care","volume":"43","author":"Adams","year":"2023","journal-title":"Prenat Diagn"},{"key":"R24-20260917","doi-asserted-by":"crossref","first-page":"101221","DOI":"10.1016\/j.gim.2024.101221","article-title":"Disparities in access to reproductive genetic services associated with geographic location of residence and maternal race and ethnicity","volume":"26","author":"Talati","year":"2024","journal-title":"Genet Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:00:12Z","timestamp":1789675212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006403","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"2026-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}